About this medicine
- Approved name
- Milaxyn Plus
- International non-proprietary name (INN) or common name
- praziquantel
- pyrantel
- febantel
- Associated names
- Strantel Plus
- Prazical Plus
- Voxical Plus
- Exitel Plus
- Cazitel Plus and Prazitel Plus
About this procedure
- Current status
- European Commission final decision
- Reference number
- EMEA/V/A/076
- Type
- Article 34
Divergent decision referral: initiated in order to obtain harmonisation within the EU of the conditions of authorisation for products already authorised by Member States.
Key dates and outcomes
- Opinion date
- 07/03/2012
- EC decision date
- 18/06/2012